Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Radium-223 Alpha Emitter Agent in Non-intervention Safety Study in mCRPC popUlation for Long-teRm Evaluation

NCT02141438 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT02141438
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02141438 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Radium-223 Alpha Emitter Agent in Non-intervention Safety Study in mCRPC popUlation for Long-teRm Evaluation
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
August 20, 2014
Completion date
October 24, 2024
Enrollment
1,472 (actual)
Sites
68

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic castration-resistant prostate cancer